BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Acetaminophen
,
rs7903146
,
SLC12A1
,
calcium channel activity
,
Hepatitis
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Fgfr1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Natural killer cell of peripheral blood
Cerebellum
Transverse colon
Saphenous vein
Mammary gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Syndactyly
Craniosynostosis syndrome
Ectrodactyly
Genodermatosis
Holoprosencephaly sequence
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
methampicillin
Pentamidine
Tetanus Toxin
AR A014418
sulfabenzamide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
CHRNA9
HNRNPA0
SETD6
SLC25A46
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoi…
The discovery of potent and stable short peptide FGFR1 antagonist for cancer therapy.
Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and…
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGF…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Olverembatinib for FGFR1-rearranged Neoplasms
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast C…
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lym…
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Gli…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ